>
"It's Begun, But Most Just Don't Know It Yet..." - Jiang Xueqin
Canadian Intelligence Scandal Deepens: New Evidence, Exposed Agents, and a Mysterious Death
The Benefits of Drinking Clove Water at Night
Deep Dive into Darkness, Future Predictions W/ Stacking Surfer & SD
Voyager 1 approaches one light day from Earth
Renewable Energy Breakthrough! World's Most Efficient Tesla Turbine System
Meet Sunbird, a nuclear fusion-powered space tug concept from Pulsar Fusion.
China and Russia launch 29-nation AI alliance to rival western control of technology
BREAKING: China has begun manufacturing domestically developed Immersion Deep...
Idaho's High Desert Becomes Hot Spot For Nuclear Power Revolution
The World's Largest Electric Aircraft Is About to Take Its First Flight
Tesla Cybercabs and Superchargers Will Act as Mini Cell Towers for SpaceX Starlink

The report analyses the science and ethics behind the Health Resources and Services Administration's (HRSA) proposed rule to redefine hematopoietic (blood-forming) stem cells (HSC) as an organ. These are the cells that originate in bone marrow but are also found in the bloodstream. Today, over 70% of HSC donations are extracted from the bloodstream through a safe, non-invasive technique known as apheresis, after which the cells quickly regenerate.
In 2011, a federal court ruled compensating donors of HSC by apheresis to be legal due to the procedure's comparability to plasma and whole blood donation. HRSA's rule change would supersede the court and violate congressional intent, thereby making compensation to all HSC donors illegal under the National Organ Transplant Act. HRSA has until December 18th to move forward on its rule.